Interesting that you take that approach here, as when people were questioning what BTD might do for the share price, I simply posted that we need to temper our expectations, because verifiable history (I provided links to reputable articles after doing some research) said that a pre-revenue biotech like CYDY could expect a week or so of increased SP (20-40%) followed by the SP going right back to where it was prior to BTD. REVENUE and revenue alone is what will drive the SP in a meaningful, material, more permanent way.

And my post was immediately deleted. That wasn't bashing, it was backed up with links, and needed to be said so that people would temper their expectations to reality.